Challenges of Legal Marijuana Consumption in Vermont and New York

Dec.07.2022
Challenges of Legal Marijuana Consumption in Vermont and New York
Vermont legalized personal marijuana use for adults, but public consumption is prohibited, making it one of the least friendly states.

In 2018, the state of Vermont passed bill number 86 which legalized the cultivation, possession and consumption of small amounts of marijuana for adults aged 21 and over in their homes. This was two years prior to legislators passing bill number 164 in 2020 which legalized commercial marijuana.


However, it remains one of the least friendly states towards legal consumption.


Who will be most affected by Vermont's cannabis consumption law, why has New York gained recognition for its new consumption law, and what can Vermont's lawmakers do to make the state more cannabis-friendly for its residents and tourists?


The states of Vermont and New York.


In Vermont, it is illegal to consume marijuana in public places. Renters, including those using short-term rentals, hotels, and Airbnb, must obtain permission from the landlord or property owner before smoking or growing marijuana in their homes, even if they are registered medical marijuana patients or caregivers.


The consumption of marijuana in Vermont is defined as any form of use, such as smoking, vaping, or consuming edibles, all of which are prohibited in public places and subject to civil penalties.


In the state of New York, it is legal to consume marijuana in any public place where smoking is allowed. Tenants and non-property owners are also allowed to consume and cultivate medical marijuana in their homes unless the landlord explicitly prohibits it.


Although New York has not yet legalized adult recreational marijuana cultivation at home, it does allow for medical cultivation and has taken impressive measures to protect the rights of medical patients and caregivers. For example, if a landlord prohibits smoking, patients are allowed to consume marijuana in other forms.


Lawmakers in New York state have placed the responsibility for compliance with their marijuana consumption law on the landlords, while lawmakers in Vermont have placed the responsibility on the tenants.


Who is protected by Vermont state law?


The state of Vermont's law limits marijuana consumption to the private residences of homeowners and tenants who have obtained explicit permission from their landlords. Therefore, homeowners are the main group protected by the law, and looking at who owns the property will tell us who is legally allowed to consume.


According to the latest US Census data, homeownership rates in Vermont by race/ethnicity are as follows: Black - 21.1%, Hispanic - 38.6%, American Indian/Alaska Native - 45.6%, Asian - 50.5%, and White - 72.6%.


Compared to other states, Vermont ranks fifth in terms of the disparity in homeownership rates for Black households nationwide. This data reveals that Black, Indigenous, and people of color communities in Vermont are least likely to own homes, and therefore have the least legal protection when it comes to consuming cannabis.


Apart from the low homeownership rate among BIPOC communities in Vermont, a report by the ACLU has found that despite the legalization of cannabis in 2018, black individuals in Vermont are arrested more frequently than their white counterparts for cannabis-related offenses, even though usage rates are similar.


Providing legal marijuana consumption spaces for all Vermont residents is an urgent public safety issue.


Tourists and visitors to Vermont are also affected by the law, as public consumption is prohibited and short-term rentals, hotels, and Airbnb require clear permits under the law. The tourism industry, which annually welcomes more than 13 million visitors, is an important sector in Vermont. If adults visiting Vermont can responsibly enjoy tobacco legally, then they should also be able to enjoy marijuana in the same way.


How can Vermont lawmakers improve the law?


Due to the recent midterm elections, the Democratic and Progressive Parties of Vermont now hold a majority in the state legislature and have the power to veto the governor's decisions.


We are calling on Vermont legislators to reexamine the marijuana consumption law during the 2023 legislative session and legalize public marijuana consumption in any location where tobacco is allowed, such as New York State. We also propose allowing non-homeowners, such as renters, to consume, possess, and grow marijuana unless explicitly prohibited by their landlord or property owner. Additionally, we suggest creating a new license category to allow consumption establishments and events, providing some form of direct-to-consumer access for growers and manufacturers.


The communities in Vermont have historically been targets of prohibition, and even with legalization, they continue to be targeted by law enforcement, not protected under the state's marijuana consumption laws. This is harmful public policy. Additionally, adult visitors to Vermont find themselves in a contradictory position, legally able to purchase marijuana and marijuana products but with no legal place to consume them.


New York lawmakers have begun securing the right for their residents and visitors to consume marijuana. Lawmakers in Vermont should follow suit by 2023, while also addressing the numerous flaws in the adult-use market, rather than replacing other jobs.


2FIRSTS will continue to track and report on this issue, with updates available on the '2FIRSTS APP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05